Programmable immunoprobiotics orchestrate antitumor immune response with Pin1 inhibition for pancreatic cancer treatment. [PDF]
Yuan S +7 more
europepmc +1 more source
Dual-site spatiotemporal and simultaneous inhibition on PIN1 via arsenic-retinoic albumin nanoparticles enables synergistic oncotherapy. [PDF]
Yang D +10 more
europepmc +1 more source
Conserved mode of nuclear lamina distortion by primate cytomegaloviruses: importance of the pSer22 motif, viral kinase and <i>cis</i>/<i>trans</i> isomerase Pin1 activity. [PDF]
Dhotre K +7 more
europepmc +1 more source
The mechanisms of Pin1 as targets for cancer therapy. [PDF]
Liu C, Dan L, Li Q, Bajinka O, Yuan X.
europepmc +1 more source
Effects of D-Amino Acid Replacements on the Conformational Stability of Miniproteins. [PDF]
Xu R, Huang J, Kuhn AJ, Gellman SH.
europepmc +1 more source
Decoding Drug Resistance in Pancreatic Cancer: A Subcellular Structure Perspective. [PDF]
Li X +11 more
europepmc +1 more source
Stereospecific NANOG PEST Stabilization by Pin1. [PDF]
Ferreon JC +8 more
europepmc +1 more source
Longitudinal prediction of drug response in high-grade serous ovarian cancer organoid cultures aligning with clinical responses. [PDF]
Cavarzerani E +9 more
europepmc +1 more source
The Actin-Binding Prolyl-Isomerase Par17 Sustains Its Substrate Selectivity by Interdomain Allostery. [PDF]
Sternberg A +9 more
europepmc +1 more source
Pin1 targets phosphorylated NCOA4 for K29/K48-linked ubiquitination to suppress ferritinophagy and ferroptosis in anaplastic thyroid cancer. [PDF]
Sun Z +10 more
europepmc +1 more source

